Soluble CD5: An Immune Activation Biomarker and Its Quantitative Detection by ELISA
Basic Introduction to CD5 Protein
CD5 is a type I transmembrane glycoprotein expressed on the surface of the vast majority of mature T lymphocytes. It is also found in small, specific quantities only on the B1a B-cell subset, and is recognized as a unique surface "identifier" of T cells. It exerts an irreplaceable regulatory function during thymic T cell development and selection, as well as the maintenance of peripheral immune homeostasis.
In terms of core physiological functions, CD5 acts as a negative regulator of immune responses. After exogenous antigens stimulate and activate the T cell receptor signaling pathway, CD5 simultaneously initiates inhibitory signals to restrict excessive T cell proliferation and over-secretion of pro-inflammatory cytokines. This prevents the immune system from indiscriminately attacking the body’s normal tissues, thereby establishing basal immune tolerance. Loss of CD5 function or abnormal CD5 expression renders the human body highly susceptible to various autoimmune lesions.
Under pathological conditions, persistent antigen stimulation continuously activates lymphocytes. Membrane-bound CD5 undergoes proteolytic cleavage and sheds from the cell surface, converting into soluble CD5 that is released into body fluids including peripheral serum, tissue homogenates, pleural effusion and ascites. Simply put, the concentration of soluble CD5 in body fluids directly reflects the overall activation level of T lymphocytes in vivo. Markedly elevated levels generally indicate chronic inflammation, autoimmune dysregulation, hematological malignancies or transplant rejection, making soluble CD5 a key biomarker for assessing immune activation in research and clinical practice.
II. Why ELISA Is the Preferred Assay for Soluble CD5 Detection
1. Assay Principle Suits the Detection of Macromolecular Soluble CD5
Soluble CD5 is a macromolecular antigen. The sandwich ELISA adopted herein is specifically designed for the quantification of large molecular proteins. The paired capture and detection antibodies supplied in the kit target two completely distinct specific epitopes on the CD5 protein to form a stable sandwich complex. The dual-antibody recognition mechanism drastically reduces cross-interference caused by homologous immune proteins and miscellaneous proteins in serum. It ensures detection specificity even for biologically complex samples and effectively avoids false positive results.
2. Kit Performance Covers the Full Range of Expression Gradients
This human CD5 sandwich ELISA kit features a linear detection range of 0.156–10 ng/mL with a limit of detection as low as 0.054 ng/mL, compatible with samples from diverse physiological and pathological stages. Basal CD5 expression in bodily fluids of healthy individuals is extremely low, yet the ultra-high sensitivity enables stable detection. High CD5 concentrations in samples from patients with autoimmune diseases or malignancies fall entirely within the standard curve range. Most samples do not require serial dilution, which greatly minimizes human error introduced by dilution steps and delivers superior data reproducibility.
3. Unique Advantages Over Other Laboratory Assays
Common immunoassays currently used in laboratories each have inherent limitations: Flow cytometry can only label and quantify the proportion of cells positive for membrane-bound CD5, and cannot quantify free soluble CD5 in body fluids at all. Western blot involves cumbersome workflows, processes only a small number of samples per run, and delivers merely semi-qualitative comparisons, making it unsuitable for statistical analysis of large sample cohorts.
In contrast, ELISA enables batch processing of 48-well or 96-well plates in a single run. Combined with automated microplate readers for rapid signal readout, it directly outputs precise protein concentration values. It is highly suitable for simultaneous testing of large batches of clinical patient cohorts and animal model samples, facilitating statistical comparison of inter-group differences.
III. Research Applications of CD5 and Its Matching ELISA Kit
As a core biomarker for evaluating immune homeostasis, CD5 supports multiple cutting-edge research areas. In autoimmune disease research, it is frequently used to monitor abnormal T cell activation and assess disease activity in patients with rheumatoid arthritis and systemic lupus erythematosus. In hematological malignancy studies, CD5 quantification assists in subtyping B-cell lymphomas and analyzing tumor malignancy and prognostic trends. In transplantation immunology, fluctuations in soluble CD5 concentration serve as an early warning marker for acute rejection following organ transplantation. Additionally, it is widely applied in chronic bacterial and viral infection models to investigate lymphocyte response patterns under sustained antigen stimulation.
Experiments performed with the human CD5 sandwich ELISA kit allow accurate quantification of endogenous soluble CD5 levels in various human biological specimens. Clear comparisons of immune activation differences can be drawn between healthy control groups, disease model groups and drug intervention groups. The kit provides objective, quantifiable experimental data to support research projects including the elucidation of immune regulatory mechanisms, efficacy evaluation of candidate therapeutics, and screening of disease biomarkers.
CD5 is a type I transmembrane glycoprotein expressed on the surface of the vast majority of mature T lymphocytes. It is also found in small, specific quantities only on the B1a B-cell subset, and is recognized as a unique surface "identifier" of T cells. It exerts an irreplaceable regulatory function during thymic T cell development and selection, as well as the maintenance of peripheral immune homeostasis.
In terms of core physiological functions, CD5 acts as a negative regulator of immune responses. After exogenous antigens stimulate and activate the T cell receptor signaling pathway, CD5 simultaneously initiates inhibitory signals to restrict excessive T cell proliferation and over-secretion of pro-inflammatory cytokines. This prevents the immune system from indiscriminately attacking the body’s normal tissues, thereby establishing basal immune tolerance. Loss of CD5 function or abnormal CD5 expression renders the human body highly susceptible to various autoimmune lesions.
Under pathological conditions, persistent antigen stimulation continuously activates lymphocytes. Membrane-bound CD5 undergoes proteolytic cleavage and sheds from the cell surface, converting into soluble CD5 that is released into body fluids including peripheral serum, tissue homogenates, pleural effusion and ascites. Simply put, the concentration of soluble CD5 in body fluids directly reflects the overall activation level of T lymphocytes in vivo. Markedly elevated levels generally indicate chronic inflammation, autoimmune dysregulation, hematological malignancies or transplant rejection, making soluble CD5 a key biomarker for assessing immune activation in research and clinical practice.
II. Why ELISA Is the Preferred Assay for Soluble CD5 Detection
1. Assay Principle Suits the Detection of Macromolecular Soluble CD5
Soluble CD5 is a macromolecular antigen. The sandwich ELISA adopted herein is specifically designed for the quantification of large molecular proteins. The paired capture and detection antibodies supplied in the kit target two completely distinct specific epitopes on the CD5 protein to form a stable sandwich complex. The dual-antibody recognition mechanism drastically reduces cross-interference caused by homologous immune proteins and miscellaneous proteins in serum. It ensures detection specificity even for biologically complex samples and effectively avoids false positive results.
2. Kit Performance Covers the Full Range of Expression Gradients
This human CD5 sandwich ELISA kit features a linear detection range of 0.156–10 ng/mL with a limit of detection as low as 0.054 ng/mL, compatible with samples from diverse physiological and pathological stages. Basal CD5 expression in bodily fluids of healthy individuals is extremely low, yet the ultra-high sensitivity enables stable detection. High CD5 concentrations in samples from patients with autoimmune diseases or malignancies fall entirely within the standard curve range. Most samples do not require serial dilution, which greatly minimizes human error introduced by dilution steps and delivers superior data reproducibility.
3. Unique Advantages Over Other Laboratory Assays
Common immunoassays currently used in laboratories each have inherent limitations: Flow cytometry can only label and quantify the proportion of cells positive for membrane-bound CD5, and cannot quantify free soluble CD5 in body fluids at all. Western blot involves cumbersome workflows, processes only a small number of samples per run, and delivers merely semi-qualitative comparisons, making it unsuitable for statistical analysis of large sample cohorts.
In contrast, ELISA enables batch processing of 48-well or 96-well plates in a single run. Combined with automated microplate readers for rapid signal readout, it directly outputs precise protein concentration values. It is highly suitable for simultaneous testing of large batches of clinical patient cohorts and animal model samples, facilitating statistical comparison of inter-group differences.
III. Research Applications of CD5 and Its Matching ELISA Kit
As a core biomarker for evaluating immune homeostasis, CD5 supports multiple cutting-edge research areas. In autoimmune disease research, it is frequently used to monitor abnormal T cell activation and assess disease activity in patients with rheumatoid arthritis and systemic lupus erythematosus. In hematological malignancy studies, CD5 quantification assists in subtyping B-cell lymphomas and analyzing tumor malignancy and prognostic trends. In transplantation immunology, fluctuations in soluble CD5 concentration serve as an early warning marker for acute rejection following organ transplantation. Additionally, it is widely applied in chronic bacterial and viral infection models to investigate lymphocyte response patterns under sustained antigen stimulation.
Experiments performed with the human CD5 sandwich ELISA kit allow accurate quantification of endogenous soluble CD5 levels in various human biological specimens. Clear comparisons of immune activation differences can be drawn between healthy control groups, disease model groups and drug intervention groups. The kit provides objective, quantifiable experimental data to support research projects including the elucidation of immune regulatory mechanisms, efficacy evaluation of candidate therapeutics, and screening of disease biomarkers.
